Browse the complete record of transactions filed by Davis Aaron I., Director. Insider active across 3 companies, notably Odonate Therapeutics, Inc.. Cumulatively, 7 disclosures have been published. Total volume traded: €5.7m. The latest transaction was disclosed on 9 May 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Aaron I. Davis is a Board Member at Odonate Therapeutics, Inc., Mirati Therapeutics, Inc., and iTeos Therapeutics, Inc. As a board member, he brings his expertise in biopharmaceuticals and strategy. His role is to oversee operations and contribute to strategic decision-making that influences the direction of the companies. He is committed to ensuring compliance and transparency within the organizations.